Risk prediction models for endometrial cancer: development and validation in an international consortium

Authors
Joy Shi
Peter Kraft
Bernard A. Rosner
Yolanda Benavente
Amanda Black
Louise A. Brinton
Chu Chen
Megan A. Clarke
Linda S. Cook
Laura Costas
Luigino Dal Maso
Jo L. Freudenheim
Jon Frias-Gomez
Christine M. Friedenreich
Montserrat Garcia-Closas
Marc T. Goodman
Lisa Johnson
Carlo La Vecchia
Fabio Levi
Jolanta Lissowska
Lingeng Lu
Susan E. McCann
Kirsten B. Moysich
Eva Negri
Kelli O'Connell
Fabio Parazzini
Stacey Petruzella
Jerry Polesel
Jeanette Ponte
Timothy R. Rebbeck
Peggy Reynolds
Fulvio Ricceri
Harvey A. Risch
Carlotta Sacerdote
Veronica W. Setiawan
Xiao-Ou Shu
Amanda B. Spurdle
Britton Trabert
Penelope M. Webb
Nicolas Wentzensen
Lynne R. Wilkens
Wang Hong Xu
Hannah P. Yang
Herbert Yu
Mengmeng Du
Immaculata De Vivo
Journal
Journal of the National Cancer Institute

Published
January 2023

Abstract
Background: Endometrial cancer risk stratification may help target interventions, screening, or prophylactic hysterectomy to mitigate the rising burden of this cancer. However, existing prediction models have been developed in select cohorts and have not considered genetic factors.

Methods: We developed endometrial cancer risk prediction models using data on postmenopausal White women aged 45-85 years from 19 case-control studies in the Epidemiology of Endometrial Cancer Consortium (E2C2). Relative risk estimates for predictors were combined with age-specific endometrial cancer incidence rates and estimates for the underlying risk factor distribution. We externally validated the models in 3 cohorts: Nurses’ Health Study (NHS), NHS II, and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Results: Area under the receiver operating characteristic curves for the epidemiologic model ranged from 0.64 (95% confidence interval [CI] = 0.62 to 0.67) to 0.69 (95% CI = 0.66 to 0.72). Improvements in discrimination from the addition of genetic factors were modest (no change in area under the receiver operating characteristic curves in NHS; PLCO = 0.64 to 0.66). The epidemiologic model was well calibrated in NHS II (overall expected-to-observed ratio [E/O] = 1.09, 95% CI = 0.98 to 1.22) and PLCO (overall E/O = 1.04, 95% CI = 0.95 to 1.13) but poorly calibrated in NHS (overall E/O = 0.55, 95% CI = 0.51 to 0.59).

Conclusions: Using data from the largest, most heterogeneous study population to date (to our knowledge), prediction models based on epidemiologic factors alone successfully identified women at high risk of endometrial cancer. Genetic factors offered limited improvements in discrimination. Further work is needed to refine this tool for clinical or public health practice and expand these models to multiethnic populations.

R Code
R code to conduct the analyses in this paper are available on Github.

Posted on:
January 23, 2023
Length:
2 minute read, 417 words
Categories:
Cancer Epidemiology
See Also: